Enterprise Therapeutics
Phase 1Respiratory diseases such as cystic fibrosis, asthma and COPD cause millions of deaths per year
Founded
2015
Focus
Small Molecules
About
Respiratory diseases such as cystic fibrosis, asthma and COPD cause millions of deaths per year
Funding History
2Total raised: $87M
Series B$58MNovartis Venture FundMar 15, 2021
Series A$29MNovo HoldingsMay 15, 2018
Company Info
TypePrivate
Founded2015
LocationBrighton, United Kingdom
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile